rs78378222 polymorphism in the 3'-untranslated region of TP53 contributes to development of age-associated cataracts by modifying microRNA-125b-induced apoptosis of lens epithelial cells

Zhao,Yang; Li,Xiao; Zhu,Siquan

doi:10.3892/mmr.2016.5465

rs78378222 polymorphism in the 3'-untranslated region of TP53 contributes to development of age-associated cataracts by modifying microRNA-125b-induced apoptosis of lens epithelial cells

Authors:
- Yang Zhao
- Xiao Li
- Siquan Zhu
View Affiliations

Affiliations: Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Tongren Hospital, Capital Medical University, Beijing 100073, P.R. China
Published online on: July 4, 2016 https://doi.org/10.3892/mmr.2016.5465
Pages: 2305-2310

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) negatively regulate the expression of the target genes by binding to ʻseed sequences’ in the 3'‑untranslated region (3'‑UTR) mRNA transcripts, and the variants within or nearby ʻseed sequences’ may compromise or enhance miRNA/mRNA interaction leading to either ʻloss‑of‑function’ or ʻgain‑of‑function’ effects. Cataracts are the leading cause of blindness worldwide and are characterized by progressive aggregation and precipitation of lens proteins, and the development of age‑related cataracts is associated with dysregulated cellular activities of lens epithelial cells. Luciferase assays and online miRNA databases were used to validate that tumor protein p53 (TP53) is the target gene of miR‑125b. Furthermore, reverse transcription‑quantitative polymerase chain reaction and western blotting were conducted to detect expression levels of miR‑125b and TP53 in different groups of cells transfected with miR‑125b mimics or inhibitors. In addition, flow cytometry analysis and the MTT assay were conducted to detect the effects of miR‑125b on apoptosis and cell viability. The current study demonstrated that the rs78378222 polymorphism minor allele introduces a novel potential miR‑125b binding site in the TP53 3'‑UTR with a consecutive 8‑bp perfect match, creating a ʻgain‑of‑function’ variant and affecting the regulation of TP53 expression. A luciferase assay demonstrated that transfection of lens epithelial cells with wild type TP53 3'‑UTR significantly reduced the luciferase activity of the miR‑125b overexpressing cells compared with scramble controls. In addition, the luciferase activity of miR‑125b overexpressing cells transfected with the construct containing the rs78378222 polymorphism minor allele was also reduced compared with cells transfected with the wild type 3'‑UTR. Furthermore, it was demonstrated that the expression level of miR‑125 was comparable in epithelial cells from patients with age‑associated cataracts and controls, whereas the expression level of TP53 was significantly higher in the cataract group compared with controls. Additionally, transfection with 50 nM miR‑125b mimics markedly reduced the mRNA and protein expression levels of TP53 in the cultured lens epithelial cells, and miR‑125b significantly induced apoptosis in the epithelial cells compared with negative control cells. In conclusion, TP53 was identified as a target of miR‑125b, and the minor allele of the rs78378222 polymorphism promoted the miR-125b/TP53 mRNA interaction.

View Figures

View References

1	Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etya'ale D, Négrel AD and Resnikoff S: 2002 global update of available data on visual impairment: A compilation of population-based prevalence studies. Ophthalmic Epidemiol. 11:67–115. 2004. View Article : Google Scholar : PubMed/NCBI
2	Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR and Mitchell P; Eye Diseases Prevalence Research Group: Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122:477–485. 2004. View Article : Google Scholar : PubMed/NCBI
3	West S: Epidemiology of cataract: Accomplishments over 25 years and future directions. Ophthalmic Epidemiol. 14:173–178. 2007. View Article : Google Scholar : PubMed/NCBI
4	Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP and Mariotti SP: Global data on visual impairment in the year 2002. Bull World Health Organ. 82:844–851. 2004.
5	Cruciani F, Amore F, Albanese G and Anzidei R: Investigation about causes of blindness and low vision among members of Blind and Visually Impaired Italian Union (UICI). Clin Ter. 162:e35–e42. 2011.PubMed/NCBI
6	WHO releases the new global estimates on visual impairment. Accessed on, http://www.who.int/blindness/en/2011.
7	Chen K and Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet. 8:93–103. 2007. View Article : Google Scholar : PubMed/NCBI
8	Peters L and Meister G: Argonaute proteins: Mediators of RNA silencing. Mol Cell. 26:611–623. 2007. View Article : Google Scholar : PubMed/NCBI
9	Karali M, Peluso I, Marigo V and Banfi S: Identification and characterization of microRNAs expressed in the mouse eye. Invest Ophthalmol Vis Sci. 48:509–515. 2007. View Article : Google Scholar : PubMed/NCBI
10	Ryan DG, Oliveira-Fernandes M and Lavker RM: MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis. 12:1175–1184. 2006.PubMed/NCBI
11	Maegdefessel L: The emerging role of microRNAs in cardiovascular disease. J Intern Med. 276:633–644. 2014. View Article : Google Scholar : PubMed/NCBI
12	Lee YH, Kim SY and Bae YS: Upregulation of miR-760 and miR-186 is associated with replicative senescence in human lung fibroblast cells. Mol Cells. 37:620–627. 2014. View Article : Google Scholar : PubMed/NCBI
13	Mimura S, Iwama H, Kato K, Nomura K, Kobayashi M, Yoneyama H, Miyoshi H, Tani J, Morishita A, Himoto T, et al: Profile of microRNAs associated with aging in rat liver. Int J Mol Med. 34:1065–1072. 2014.PubMed/NCBI
14	Khee SG, Yusof YA and Makpol S: Expression of senescence-associated microRNAs and target genes in cellular aging and modulation by tocotrienol-rich fraction. Oxid Med Cell Longev. 2014:7259292014.PubMed/NCBI
15	Hughes AE, Bradley DT, Campbell M, Lechner J, Dash DP, Simpson DA and Willoughby CE: Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet. 89:628–633. 2011. View Article : Google Scholar : PubMed/NCBI
16	Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
17	Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S and Ørum H: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327:198–201. 2010. View Article : Google Scholar
18	Wang Z, Rajaraman P, Melin BS, Chung CC, Zhang W, McKean-Cowdin R, Michaud D, Yeager M, Ahlbom A, Albanes D, et al: Further confirmation of germline glioma risk variant rs78378222 in TP53 and its implication in tumor tissues via integrative analysis of TCGA data. Hum Mutat. 36:684–688. PubMed/NCBI
19	Guan X, Wang LE, Liu Z, Sturgis EM and Wei Q: Association between a rate novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of the head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med. 17:873–878. 2013. View Article : Google Scholar : PubMed/NCBI
20	Long AC, Bomser JA, Grzybowski DM and Chandler HL: All-trans retinoic acid regulates cx43 expression, gap junction communication and differentiation in primary lens epithelial cells. Curr Eye Res. 35:670–679. 2010. View Article : Google Scholar : PubMed/NCBI
21	Carlson RV, Boyd KM and Webb DJ: The revision of the Declaration of Helsinki: Past, present and future. Br J Clin Pharmacol. 57:695–713. 2004. View Article : Google Scholar : PubMed/NCBI
22	Chylack LT Jr, Wolfe JK, Singer DM, Leske MC, Bullimore MA, Bailey IL, Friend J, McCarthy D and Wu SY: The lens opacities classification system III. The longitudinal study of cataract study group. Arch Ophthalmol. 111:831–836. 1993. View Article : Google Scholar : PubMed/NCBI
23	Ferracin M, Bassi C, Pedriali M, Pagotto S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L, et al: miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Mol Cancer. 12:1302013. View Article : Google Scholar : PubMed/NCBI
24	Sun YM, Lin KY and Chen YQ: Diverse functions of miR-125 family in different cell contexts. J Hematol Oncol. 6:62013. View Article : Google Scholar : PubMed/NCBI
25	Bousquet M, Nguyen D, Chen C, Shields L and Lodish HF: MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA. Haematologica. 97:1713–1721. 2012. View Article : Google Scholar : PubMed/NCBI
26	Ge Y, Sun Y and Chen J: IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol. 192:69–81. 2011. View Article : Google Scholar : PubMed/NCBI
27	Bi Q, Tang S, Xia L, Du R, Fan R, Gao L, Jin J, Liang S, Chen Z, Xu G, et al: Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One. 7:e401692012. View Article : Google Scholar : PubMed/NCBI
28	Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A: MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J Biol Chem. 287:29899–29908. 2012. View Article : Google Scholar : PubMed/NCBI
29	Thomas DC, Haile RW and Duggan D: Recent developments in genomewide association scans: A workshop summary and review. Am J Hum Genet. 77:337–345. 2005. View Article : Google Scholar : PubMed/NCBI
30	Rao AK, Vinothkumar V, Revathidevi S, Arunkumar G, Manikandan M, Arun K, Rajkumar KS, Ramani R, Ramamurthy R and Munirajan AK: Abscence of the TP53 poly-A signal sequence variant rs78378222 in oral, cervical and breast cancers in South India. Asian Pac J Cancer Prev. 15:9555–9556. 2014. View Article : Google Scholar
31	Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH and Thompson RC: Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet. 49:420–421. 2012. View Article : Google Scholar : PubMed/NCBI
32	Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, et al: A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 43:1098–1103. 2011. View Article : Google Scholar : PubMed/NCBI